Viatris (VTRS) FCF Margin Growth (1y) (2020 - 2026)
Viatris (VTRS) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 74.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -247.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 546.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -209.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -522.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 828.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 301.00 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1,940.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -522.00 |
| Dec 31, 2025 | 673.00 |
| Sep 30, 2025 | -248.00 |
| Jun 30, 2025 | -379.00 |
| Mar 31, 2025 | -27.00 |
| Dec 31, 2024 | -78.00 |
| Sep 30, 2024 | 119.00 |
| Jun 30, 2024 | -321.00 |
| Mar 31, 2024 | -934.00 |
| Dec 31, 2023 | 971.00 |
| Sep 30, 2023 | -2.00 |
| Jun 30, 2023 | -583.00 |
| Mar 31, 2023 | -94.00 |
| Dec 31, 2022 | -649.00 |
| Sep 30, 2022 | -253.00 |
| Jun 30, 2022 | 720.00 |
| Mar 31, 2022 | 754.00 |
| Dec 31, 2021 | 962.00 |
| Mar 31, 2021 | 860.00 |
| Dec 31, 2020 | -1,809.00 |